Immediate medical attention is required if thirst is accompanied by any of the following: Severe or persistent vomiting or diarrhoea leading to inability to maintain hydration Signs of dehydration such as dizziness, reduced urine output, dark-coloured urine, or dry mucous membranes Symptoms suggestive of hypoglycaemia (blood glucose below 4 mmol/L) that do not resolve with standard treatment Severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect of GLP-1 receptor agonists Symptoms of DKA, including rapid breathing, fruity breath odour, confusion, or loss of consciousness If pancreatitis is suspected (severe, persistent abdominal pain, possibly radiating to the back), stop taking semaglutide and seek urgent medical assessment
Calcitriol then stimulates increased absorption of dietary calcium by the intestines
Semaglutide with B12 complete guide details that formulation, which uses a single GLP-1 receptor agonist approach
the most common adverse events are gastrointestinal [GI]-related [14, 15]
Patients should follow their healthcare providers instructions for use and attend regular follow-up appointments to monitor progress and assess the need for continued treatment